mirtazapine has been researched along with Corneal Dystrophies in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, D | 1 |
| Yasui, K | 1 |
| Hasegawa, Y | 1 |
| Nakamichi, K | 1 |
| Katsuno, M | 1 |
| Takahashi, A | 1 |
1 other study available for mirtazapine and Corneal Dystrophies
| Article | Year |
|---|---|
Progressive multifocal leukoencephalopathy with bilateral middle cerebellar peduncle lesions confirmed by repeated CSF-JC virus tests and coexistence of JC virus granule cell neuronopathy. Report of a case.
Topics: Aged; Cerebellum; Cerebrospinal Fluid; Corneal Dystrophies, Hereditary; Diagnosis, Differential; DNA | 2016 |